Human polymorphonuclear leukocytes: Effect of chloroquine on aggregation, arachidonic acid liberation and thromboxane B2 generation

General Physiology and Biophysics

Volumn 15, Issue 6, 1996, Pages 489-494

  Kotuliakova K ^a   Nosal R ^b   Pecivova J ^a   Drabikova K ^a   Macickova T ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Aggregation; Arachidonic acid liberation; Chloroquine; Human PMN leukocytes; Thromboxane B2 formation

Indexed keywords

ARACHIDONIC ACID; CHLOROQUINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; THROMBOXANE B2;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; NEUTROPHIL; NORMAL HUMAN;

ARACHIDONIC ACID; CELL AGGREGATION; CHLOROQUINE; HUMANS; NEUTROPHILS; THROMBOXANE B2;

EID: 0030403168     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Boyum M. (1968): Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21, 77-90
2. Cummins D., Faint R., Yardumian D. A., Dawling S., Mackie I., Macchin S. J. (1990): The in vitro and ex vivo effect of chloroquinc sulfate on platelet function: implications of malaria prophylaxis in patients with impaired haemostasia. J. Trop. Med. Hyg. 93, 112-115
3. Drábiková K., Pečivová J., Nosál R. (1996): Effect of chloroquine on arachidonic acid pathway in isolated mast cells. Inflamm. Res. 45, S13-S14
4. Hurst N. P., French J. K., Bell A. L., Nuki G., O'Donnell M. L., Betts W. H., Cleland L. G. (1986): Differential effect of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem. Pharmacol. 18, 3083-3089
5. Hurst N. P., French J. K., Gorjatschko L., Betts W. H. (1987): Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leukocyte superoxide production by chloroquine and hydroxychloroquine. Ann. Rheum. Dis. 46, 750-756
6. Jančinová V., Nosál R. (1989): Difference among beta adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation. Thromb. Res. 54, 687-698
7. Jančinová V., Nosál R., Petríková M. (1994): On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb. Res. 74, 495-504
8. Jančinová V., Nosál R., Danihelová E. (1996): Inhibition of human blood platelets by chloroquine. Platelets 7, P88
9. Nosál R., Ericsson O.. Sjoqvist F., Ďurišová M. (1988): Distribution of chloroquine in human blood fractions. Meth. Find. Exptl. Clin. Pharmacol. 10, 581-587
10. Nosál R., Drábiková K., Pečivová J. (1991): Effect of chloroquine on isolated mast cells. Agent. Action 33, 37-40
11. Nosál R., Petríková M., Jančinová V. (1993): Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs. J, Lipid Med. 8, 121-132
12. Nosál R., Jančinová V., Petríková M. (1995): Chloroquine inhibits stimulated platelets at the arachidonic acid pathway. Thromb. Res. 77, 531-542
13. Ohkuma O., Poole B. (1978): Fluorescence probe measurement of the intralysosomal pH in leaving cells an the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75, 3327-3331
14. Poole B., Ohkuma O. (1981): Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell. Biol. 90, 665-669
15. Sha'afi R. I., Molski T. F. P. (1988): Activation of the neutrophil. Progr. Allergy 42, 1-64
16. Titus E. O. (1989): Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine. Ther. Drug Monit. 11, 369-379
17. Wise H., Jones R. L. (1994): Characterization of prostanoid receptors on rat neutrophils. Br. J. Pharmacol, 113, 581-587